← All stocks

Encompass Health Corp

EHC Net selling
CIK 0000785161 #861 in the set updated 17 Sep 2026
Bought (1 mo)
$0.00
out of their own pocket, the only kind of buying there is
Sold (1 mo)
$1.22M
$0.00 on a plan · $588.26K straight out of an exercise
Sold at will
$630.17K
1 of 2 sales
Net
−$1.22M
−$630.17K against sales at will

By person

17 insiders · 2 transactions
29.4×

Mark J. Tarr holds 29.4 times base salary in stock. $32.43M of shares against $1.10M in salary for 2025.

Salary from the company's own proxy. The shares are what Mark J. Tarr last reported holding, valued at $121.09, the price Encompass Health Common Stock was last bought or sold at on the open market here, on 31 Aug 2026.

Insider
Role
Bought
Sold
Net
Holding
Of company
Worth
Change
Price Andrew L
Chief Accounting Officer
$630.17K (1)
−$630.17K
69,483
0.0704%
$8.41M
−9.4%
Darby John Patrick
EVP, Gen Counsel & Secretary
$588.26K (1) scheduled
−$588.26K
75,041
0.0761%
$9.09M
−11.5%
Tarr Mark J
President & CEO
267,814
0.2715%
$32.43M
−51.7%
Fay Edmund
Sr. Vice Pres. and Treasurer
86,325
0.0875%
$10.45M
−15.4%
COLTHARP DOUGLAS E
EVP & Chief Financial Officer
77,988
0.0791%
$9.44M
−20.8%
KATZ LESLYE G
Director
49,643
0.0503%
$6.01M
+8.1%
HERMAN JOAN E
Director
49,643
0.0503%
$6.01M
+8.1%
Tuer Patrick William
EVP, Chief Operating Officer
24,755
0.0251%
$3.00M
+78.3%
SCHLICHTING NANCY M
Director
22,972
0.0233%
$2.78M
+17.1%
CARMICHAEL GREG D
Director
20,349
0.0206%
$2.46M
+19.1%
Reidy Christopher R
Director
17,777
0.0180%
$2.15M
+49.9%
Charbonneau Elissa Joy
Chief Medical Officer
17,644
0.0179%
$2.14M
−5.1%
Williams Terrance
Director
16,859
0.0171%
$2.04M
+24.0%
Maryland Patricia Anne
Director
14,764
0.0150%
$1.79M
+11.5%
O'Connor Kevin J.
Director
11,582
0.0117%
$1.40M
+37.9%
Christie Edward M III
Director
9,345
0.0095%
$1.13M
+126.7%
Hayes Cain A
Director
2,096
0.0021%
$253.80K
Insider
Date
Role
Action
Shares
Price
Amount
Darby John Patrick
31 Aug 2026
EVP, Gen Counsel & Secretary
Sold after exercise
4,858
$121.09
$588.26K

What was left out

Form 4 filings counted 2
Amendments (4/A) skipped 0
Filings about a different issuer 0
Unreadable filings 0
Joint filings 0
Sales on a Rule 10b5-1 plan 0
Sales straight out of an exercise 1
Sales at will 1
Transactions with no price 0
Shares from compensation/vesting 4,858
History held since 19 Oct 2016